The Protein Sequencing Market is expanding as advances in proteomics, biotechnology, pharmaceutical research, and personalized medicine increase the need to understand protein structures and amino acid sequences. According to a recent report by Market Research Future, the market was valued at USD 1.47 billion in 2024 and is projected to reach USD 6.49 billion by 2035, registering a CAGR of approximately 14.45% during 2025–2035. Protein sequencing enables researchers to determine the amino acid composition and sequence of proteins, supporting applications ranging from biomedical research to drug discovery and diagnostics. Market Growth is being supported by increasing investment in proteomics research and the development of advanced analytical technologies. Pharmaceutical and biotechnology companies are increasingly using protein sequencing to investigate disease mechanisms, identify biomarkers, validate therapeutic targets, and support biopharmaceutical development. Growing interest in personalized medicine is also encouraging researchers to examine protein-level variations that can influence disease progression and treatment response. As research laboratories generate increasingly complex biological datasets, demand for reliable sequencing technologies and analytical tools is expected to continue increasing.

The future of the Protein Sequencing Market is expected to be shaped by high-throughput technologies, improved mass spectrometry capabilities, automation, and advanced data analysis. Market Trends indicate increasing integration of protein sequencing with broader proteomics and systems biology workflows. North America currently represents the largest regional market, while Asia-Pacific is emerging as a rapidly expanding region due to increasing research and development investments. Market Analysis suggests that pharmaceutical companies, biotechnology organizations, academic institutions, and contract research organizations will remain important end users. Improvements in sequencing accuracy, speed, and data interpretation can create additional opportunities for technology providers. Market Forecast expectations remain positive as researchers continue exploring protein structures and functions to support new therapeutic discoveries, diagnostics, and precision medicine applications.